KMB vs PTGX · P/E 19, rev $8.35B vs rev $269.8M
Kimberly-Clark Corporation (KMB) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the KMB and PTGX stock pages for the full models.
Not investment advice.